December 13, 2007 
I only have one more post queued up on content from the Outcomes conference. Here is some data on specialty drugs that shows the growth, their percentage of the market, the prevalence, and the cost per patient.
Leave a comment
Share This
My LinkedIn Profile
WSJ Health Blog
- Is a Paleo Diet Healthier Than Standard Nutritional Guidelines?
- Small Business and the Affordable Care Act: How Has Your Business Been Affected?
- HealthCare.gov Explorer: Decode the Health Law’s Subsidies
- One Reporter, Four Families, Six Scientists and the Search to Cure a Rare Disease
- Your Responses: How Has the Health Law Affected You?
- What Does the Health Law Mean for You? Your Questions Answered
- How Has the Health Law Affected You?
- Rare Diseases and the Search for a Cure: A Reddit AMA
- Robots to Cure Rare Diseases: A Reddit Ask Me Anything (AMA)
- Six Tips For Better Napping
Drug Channels
- The Spinoff: How Biosimilars Are Becoming Wholesalers' Next Hit Show
- Keep Your Patient Program at the Forefront of Innovation at Patient Pathways: The Copay and Patient Services Congress
- Fixing the Front Door Isn’t the Same as Fixing Time to Therapy
- Preorder DCI’s New 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors
- Informa Connect’s Pharma/Biotech GTN Summit
- Drug Channels Leadership Forum 2027: Antonio Ciaccia to Serve as Moderator
- BlinkRx Insights: Beyond the Hub - Rethinking the Prescription Journey
- The Private Label Biosimilar Paradox in Medicare Part D
- Medicare, Medicaid, and Reverification: What Patient Support Programs Need to Know Before January 2027
- Drug Channels News Roundup, August 2026: 340B Rebate Model v2, Patients Feeling Drug Costs, Specialty Drug Spending Drivers, Impact on Coverage from the IRA, and a Drug Price Adventure
KevinMD Blog
- An error has occurred; the feed is probably down. Try again later.
Health Populi
- Health for Everyone, Everyone for Health – Meeting Dr. Max Pharmacy in Italy
- One in Two Americans Who Have Used AI Believe They Can Address Health Concerns At Least As Well As Health Care Providers – The 2026 Edelman Trust Barometer Look at AI, Health Care, and Trust
- In 2027, Employers Will Face the Highest Health Benefit Cost Increases Since 2003 – Is This the Beginning of Workplace Health Erosion?
- When the Cost of Food is a Health Risk: Dollar Stores, Tariffs, Family Meals, and the Rising Cost of Food
- A Bullish Market for Wearables and the Health-Driven Consumer
- How Kroger and Instacart Are Delivering Food as Medicine, and Medicine with Food
- The Cost of Healthcare for Retirees in America Hit $185,500 for a Person Retiring in 2026 – Welcome to Fidelity Investment’s 25th Annual Report
- How to Segment AI-Using Consumers: The Harris Poll AI Atlas, and What It Means for Healthcare
- Americans’ Spending on Healthcare, Food, and Housing: It’s All the Costs of Living – eHealth’s 2026 Mid-Year Survey
- Health in Media at FIFA World Cup 2026 – Viva España, Wellbeing, and Love
e-Patients
- The Patient Journey: Amyloidosis
- A New Measure for Patient – Physician Interactions
- SPM at the World Orphan Drug Conference
- Introducing the CHAMP Principal Investigator: Cait DesRoches (Part 2)
- Introducing the CHAMP Principal Investigator: Cait DesRoches (Part 1)
- Everylife Foundation Community Congress Annual Meeting Highlights
- Collaboration is the Best Medicine: Patient-Centered Collaboration Grounded in Caritas®
- Collaboration is the Best Medicine: It’s the Heart of Caregiving
- Collaboration is the Best Medicine: How to Partner with Your Doctor for Better Care
- Collaboration is the Best Medicine: Bridging the Gap in Patient Participation
Enabling Healthy Decisions Blog by www.georgevanantwerp.com is licensed under a Creative Commons Attribution-Noncommercial-No Derivative Works 3.0 United States License.
Contact Information
Contact me at gvanantwerp @ mac.com.
No comments yet... Be the first to leave a reply!